Stay updated with breaking news from Saphyr Chip. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bionano Genomics (NASDAQ:BNGO – Free Report) had its target price cut by Scotiabank from $7.00 to $6.00 in a research note issued to investors on Thursday morning, Benzinga reports. They currently have a sector outperform rating on the stock. Separately, Maxim Group restated a hold rating on shares of Bionano Genomics in a report on […]
Bionano Genomics (NASDAQ:BNGO – Get Free Report) and Revvity (NYSE:RVTY – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, valuation, risk and dividends. Valuation & Earnings This table compares Bionano Genomics and […]
Inspire Advisors LLC lowered its position in Bionano Genomics, Inc. (NASDAQ:BNGO – Free Report) by 90.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 39,595 shares of the company’s stock after selling 355,352 shares during the period. Inspire Advisors LLC […]
Bionano Genomics, Inc. (NASDAQ:BNGO – Get Free Report) was the recipient of a significant growth in short interest during the month of November. As of November 15th, there was short interest totalling 7,080,000 shares, a growth of 7.1% from the October 31st total of 6,610,000 shares. Currently, 18.6% of the shares of the company are […]
Bionano Genomics, Inc. (NASDAQ:BNGO – Get Free Report) was the target of a significant growth in short interest in October. As of October 31st, there was short interest totalling 6,610,000 shares, a growth of 15.6% from the October 15th total of 5,720,000 shares. Approximately 19.1% of the shares of the stock are sold short. Based […]